Working Together to Put Patients First
Fortune US
|October - November 2023
Averitas Pharma fosters a culture of caring and collaboration rooted in integrity.
-
THE LEADERSHIP AT AVERITAS PHARMA, a Grünenthal company, believes the organization's remarkable journey thus far has been the result of its people. The team at the pioneering specialty pharmaceutical company strives to transform the lives of individuals grappling with pain. Averitas' dedication to appropriate patients shapes everything it does, and its vision goes beyond pain alleviation; the organization aspires to empower individuals to move beyond the limitations of pain.
Bu hikaye Fortune US dergisinin October - November 2023 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Fortune US'den DAHA FAZLA HİKAYE
Fortune US
GET READY TO OWN A TOKENIZED PORTFOLIO
A BLOCKCHAIN \"FREIGHT TRAIN\" IS ALREADY REMAKING WALL STREET'S FINANCIAL PLUMBING. IT COULD MAKE TRADING EVEN FASTER AND CHEAPER
6 mins
December 2025 - January 2026
Fortune US
RESOURCES HOW RARE EARTHS BECAME GROUND ZERO IN THE U.S.-CHINA RIVALRY
THE WATERSHED moment came in July when the federal government became the largest shareholder of MP Materials, a California miner of rare earth elements.
2 mins
December 2025 - January 2026
Fortune US
PASSIONS A BLISSFUL ESCAPE FROM DECISION FATIGUE
THE TASTING MENU at Uberto ends, like many others at restaurants of this caliber, with mignardises.
4 mins
December 2025 - January 2026
Fortune US
JAMIE DIMON OF JPMORGAN CHASE ON STEERING AMERICA'S BIGGEST BANK THROUGH 'INFLATIONARY' TIMES
CEO JAMIE DIMON has led JPMorgan Chase through periods of rapid change and epic turmoil—and Jan. 1, 2026, will be his 20th anniversary in the role.
6 mins
December 2025 - January 2026
Fortune US
WHAT TO BUY, AND NOT BUY, IN 2026
THREE YEARS OF EUPHORIA IN STOCKS AND OTHER ASSETS HAVE INVESTORS BRACING FOR TROUBLE. HERE'S WHAT TO DO IF BAD NEWS ARRIVES.
7 mins
December 2025 - January 2026
Fortune US
Breaking the Mold
The Trade Desk's Al-powered platform and open-web ethos has propelled it onto the S&P 500.
2 mins
December 2025 - January 2026
Fortune US
WINE TARIFF THREATS AND GEN Z SOBRIETY HAVE PUT BORDEAUX ON RED ALERT
IN THE TASTING room of a Bordeaux winery, a photo on the wall shows a pastoral tableau: three generations of the Dubois family, sipping wine on the patio of their Les Bertrands château, with their Australian shepherd, Namek, perched at their feet.
6 mins
December 2025 - January 2026
Fortune US
HOW AN AI BUBBLE COULD RUIN THE PARTY
IF AI REVENUE DOESN'T CATCH UP WITH AI SPENDING, GLOBAL STOCKS WILL BE AT RISK.
6 mins
December 2025 - January 2026
Fortune US
INNOVATION IS THE ERA OF ROBOT-DRIVEN UNEMPLOYMENT ALMOST UPON US?
AT A PRESS EVENT LAST YEAR, Amazon Robotics chief technologist Tye Brady told Fortune that the idea that there's a battle of robots versus humans inside Amazon's warehouse network is a “myth.”
5 mins
December 2025 - January 2026
Fortune US
Nvidia is invincible. Unless it isn't.
The doubters are coming for the world's most valuable company.
11 mins
December 2025 - January 2026
Translate
Change font size

